By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Clal Biotechnology Industries Ltd. (CBI) 

Hogi Tower
12 Abba Hillel Silver Street
Ramat Gan    52506  Israel
Phone: 972-03-612-1616 Fax: N/A


Key Statistics

Ownership: Public

Web Site: Clal Biotech
Symbol: CLALF

Company News
Clal Biotech (CLALF) Appoints Julian Adams, Ph.D. As Chief Science Officer And President 1/31/2017 9:19:37 AM
Clal Biotech (CLALF) Opts Out of Re-Acquiring Andromeda from Hyperion (HPTX) After Phase III Diabetes Drug Tanks 10/7/2015 7:45:40 AM
Hyperion Therapeutics (HPTX) Enters Into Completion Of Phase III Clinical Trial, Option And Mutual Release Agreement With Clal Biotechnology Industries And Yeda Research and Development Company Ltd. 2/17/2015 7:22:49 AM
Hyperion Therapeutics (HPTX), Clal Biotechnology Industries Resolve Dispute Over $570 Million Biotech Problem 10/7/2014 7:16:31 AM
Clal Biotechnology Industries Release: Andromeda Announces That Further Data Analyses Support Primary Endpoint in Andromeda Biotech's Phase III Clinical Study 5/10/2012 10:15:06 AM
Teva Pharmaceutical Industries Limited (TEVA), Clal Biotechnology Industries Raises Stake in Diabetes Treatment Developer, Andromeda; Teva and Clal to Invest $17.5 Million 6/14/2010 6:45:58 AM
Yissum Ltd., Pontifax, and Clal Biotechnology Industries Invest $9 Million in Avraham Pharmaceuticals Ltd. to Pursue a Phase IIb Clinical Trial of Ladostigil, a Novel Drug for Treatment of Alzheimer's Disease 4/14/2010 6:40:38 AM
Arte Ventures And Clal Biotechnology Industries Introduce A New Model For Biotech Investment Management 3/27/2006 1:08:30 PM
Teva Pharmaceutical Industries Limited (TEVA) Buys 19% Of Clal Biotechnology Industries For $19 Million10/19/2005 5:09:17 PM